A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines - 24/08/11
Corresponding author. Address: Department of Dermatology, Microbiology and Immunology and Internal Medicine, UTMB Center for Clinical Studies, 2060 Space Park Drive, Suite 200, Houston, TX 77058, USA. Tel.: +1-281-333-2288; fax: +1-281-335-4605Abstract |
Viral vaccines could be considered among the most important medical achievements of the 20th century. They have prevented much suffering and saved many lives. Although some curative antiviral drugs exist, we desperately depend on efforts by academic, governmental and industrial scientists in the advancement of viral vaccines in the prevention and control of infectious diseases. In the next decade, we hope to see advancement in the development of current and investigational viral vaccines against childhood and adult infections. In this article, we will review the licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.
Le texte complet de cet article est disponible en PDF.Keywords : Viral vaccines, Safety, Investigational
Plan
Vol 49 - N° 3
P. 179-209 - octobre 2004 Retour au numéro
- Heroes of SARS: professional roles and ethics of health care workers
- Dena Hsin-Chen Hsin, Darryl R.J. Macer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?